186 related articles for article (PubMed ID: 18677922)
1. [Structural changes of tumor microenvironment in liver metastases of colorectal carcinoma].
Giuşcă SE; Carasevici E; Eloae-Zugun F; Târcoveanu E; Căruntu ID
Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):165-73. PubMed ID: 18677922
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of colorectal cancer liver metastases: the immune/inflammatory infiltrate.
Giuşcă SE; Zugun FE; Târcoveanu E; Carasevici E; Amălinei C; Căruntu ID
Rom J Morphol Embryol; 2010; 51(1):73-9. PubMed ID: 20191123
[TBL] [Abstract][Full Text] [Related]
3. Morphological aspects of the hepatic response to neoadjuvant therapy.
Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
[TBL] [Abstract][Full Text] [Related]
5. Biology of colorectal liver metastases.
Ahmad SA; Berman RS; Ellis LM
Surg Oncol Clin N Am; 2003 Jan; 12(1):135-50. PubMed ID: 12735135
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic microvessel density as prognostic marker in colorectal cancer.
Saad RS; Kordunsky L; Liu YL; Denning KL; Kandil HA; Silverman JF
Mod Pathol; 2006 Oct; 19(10):1317-23. PubMed ID: 16799477
[TBL] [Abstract][Full Text] [Related]
7. Predicting early intrahepatic recurrence after curative resection of colorectal liver metastases with molecular markers.
Narita M; Oussoultzoglou E; Chenard MP; Fuchshuber P; Yamamoto T; Addeo P; Jaeck D; Bachellier P
World J Surg; 2015 May; 39(5):1167-76. PubMed ID: 25561185
[TBL] [Abstract][Full Text] [Related]
8. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in synchronous and metachronous colorectal liver metastases: the liver as a permissive soil.
van der Wal GE; Gouw AS; Kamps JA; Moorlag HE; Bulthuis ML; Molema G; de Jong KP
Ann Surg; 2012 Jan; 255(1):86-94. PubMed ID: 22156924
[TBL] [Abstract][Full Text] [Related]
10. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma.
Maehara Y; Kabashima A; Koga T; Tokunaga E; Takeuchi H; Kakeji Y; Sugimachi K
Surgery; 2000 Sep; 128(3):408-16. PubMed ID: 10965312
[TBL] [Abstract][Full Text] [Related]
11. Hepatic tumor growth: target for angiogenesis inhibition?
Sarraf-Yazdi S; Mi J; Clary BM
World J Surg; 2005 Mar; 29(3):287-92. PubMed ID: 15706441
[TBL] [Abstract][Full Text] [Related]
12. NM23 protein expression in colorectal carcinoma using TMA (tissue microarray): association with metastases and survival.
Oliveira LA; Artigiani-Neto R; Waisberg DR; Fernandes LC; Lima Fde O; Waisberg J
Arq Gastroenterol; 2010; 47(4):361-7. PubMed ID: 21225146
[TBL] [Abstract][Full Text] [Related]
13. Challenges in everyday surgical practice: synchronous bilobar hepatic colorectal metastases--newer multimodality approach.
Lygidakis NJ; Bhagat AD; Vrachnos P; Grigorakos L
Hepatogastroenterology; 2007 Jun; 54(76):1020-4. PubMed ID: 17629030
[TBL] [Abstract][Full Text] [Related]
14. Reversal of attachment to or invasion of major intrahepatic vessels by colorectal liver metastases according to prehepatectomy chemotherapy regimen.
Tanaka K; Nakagawa K; Yabushita Y; Hiroshima Y; Matsuo K; Ota M; Ichikawa Y; Taguri M; Tanabe M; Koda K; Endo I
Surgery; 2014 May; 155(5):936-44. PubMed ID: 24656858
[TBL] [Abstract][Full Text] [Related]
15. Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
Eefsen RL; Engelholm L; Willemoe GL; Van den Eynden GG; Laerum OD; Christensen IJ; Rolff HC; Høyer-Hansen G; Osterlind K; Vainer B; Illemann M
Int J Cancer; 2016 Apr; 138(7):1777-84. PubMed ID: 26510166
[TBL] [Abstract][Full Text] [Related]
16. [Roles of hepatectomy for colorectal liver metastases with necrotic foci caused by prior anti-cancer therapies].
Ko S; Mukogawa T; Ishikawa H; Inoue T; Nishiwada T; Nakamoto T; Kunishige T; Watanabe A
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2569-72. PubMed ID: 21224642
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of anti-angiogenic therapy in metastatic colorectal cancer (mCRC): original data and review of the literature.
Pohl M; Werner N; Munding J; Tannapfel A; Graeven U; Nickenig G; Schmiegel W; Reinacher-Schick A
Z Gastroenterol; 2011 Oct; 49(10):1398-406. PubMed ID: 21964893
[TBL] [Abstract][Full Text] [Related]
18. Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases.
Maru DM; Kopetz S; Boonsirikamchai P; Agarwal A; Chun YS; Wang H; Abdalla EK; Kaur H; Charnsangavej C; Vauthey JN; Loyer EM
Am J Surg Pathol; 2010 Sep; 34(9):1287-94. PubMed ID: 20697255
[TBL] [Abstract][Full Text] [Related]
19. Cell proliferation-related markers in colorectal liver metastases: correlation with patient prognosis.
Costa A; Doci R; Mochen C; Bignami P; Faranda A; Gennari L; Silvestrini R
J Clin Oncol; 1997 May; 15(5):2008-14. PubMed ID: 9164212
[TBL] [Abstract][Full Text] [Related]
20. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies.
Lazaris A; Amri A; Petrillo SK; Zoroquiain P; Ibrahim N; Salman A; Gao ZH; Vermeulen PB; Metrakos P
J Pathol Clin Res; 2018 Jul; 4(3):184-192. PubMed ID: 29654716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
